Parkinson's Clinical Trial Companion Accelerating Clinical Trials | Page 29

CA SE STUDY NO. 6 Institute for Neurodegenerative Disorders Physician Referral Network Physicians play a critical role in facilitating patient participation in clinical research. 17 In fact, a poll by Research!America found that 72 percent of respondents would participate in a trial if their doctor recommended it. 18 However, primary care physicians and neurologists often are not involved in the recruitment strategy for clinical trials. Historical barriers have made engagement with physicians challenging. They may fear losing care of patients to clinical trial site providers, be unfamiliar with the trial and principal investigator, or have concerns about jeopardizing the doctor-patient relationship. 19,20 One approach to building trust and overcoming these obstacles is for research institutions and principal investigators to actively engage with community physicians. Reaching out to local physicians to increase knowledge about trials and generate confidence can facilitate referrals. The Institute for Neurodegenerative Disorders (IND) serves as a prime example of how research institutions can better engage with community physicians to build referral networks. Founded in New Haven, Connecticut, in 2001, IND develops diagnostic tools and treatments for individuals with neurodegenerative disorders. Its founders, Kenneth Marek, MD, and John Seibyl, MD, bucked the traditional research institution model. Foregoing regular clinic hours, they focused instead entirely on clinical research studies. This novel approach meant that trials conducted at IND had to rely heavily on patient referrals from community clinicians. Through several years of dedicated outreach to clinicians in the community, IND built a referral network of neurologists located across the state of Connecticut. As a result, the top two referral sources for trials at IND are: 1) new patient referrals from community clinicia ns, and 2) a database of patients referred to past IND studies. This resource of patient referrals has made IND a top recruiting site for Parkinson's studies, including the Parkinson’s Progression Marker Initiative (ppmi-info.org). The Institute of Neurodegenerative Disorders may seem uniquely positioned for success in the development of a physician referral network, but Director of Clinical Research David S. Russell, MD, PhD, believes that traditional research institutions can easily replicate these efforts. Dr. Russell outlines a three-tiered strategy to facilitate engagement and long-term relationship building among community physicians: + + Conduct Due Diligence – – Learn about the practices in your community. To maximize your time and effort, do online research about local practices. Begin with neurology clinics that see individuals with Parkinson's disease (PD). Identify a neurologist, physician assistant or nurse practitioner who regularly treats PD patients. Consider connecting with primary care physicians and allied health care professionals, but prioritize neurologists as they more frequently engage with PD patients. For IND, neurologists historically have provided the most referrals. – – Understand the needs of community clinicians. Ask physicians about challenges they may be facing in their practices. For example, a community neurologist may be having difficulties diagnosing a patient. Offer to provide an expert second opinion and send your recommendations. Point out research studies that include procedures and assessments that physicians may find useful to treat their patients. For instance, Dr. Russell has found that community physicians often seek DaTscans for their patients. In addition, explain the various patient wellness programs available at your site, such as support groups, PD education events and fitness classes. Patients can learn about recruiting trials at your site through these programs. Continued on page 28 http://www.appliedclinicaltrialsonline.com/print/343713?page=full https://www.elsevier.com/connect/poll-majority-of-americans-would-participate-in-clinical-trials-if-recommended-by-doctor 19 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782313/ 20 Michaels, Margo, et al. “Impact of Primary Care Provider Knowledge, Attitudes, and Beliefs about Cancer Clinical Trials: Implications for Referral, Education and Advocacy.” Journal of Cancer Education, vol. 30, no. 1, 2015, pp. 152-157, Research Library, 17 18 Chapter 3 — Building a Recruitment Strategy and Toolkit 27